Posts Tagged: cancer


The Unpredictable Prospects of Patenting Cancer Innovation

Art Unit 1618 and 1621 are both identified as relating to “organic compounds – part of the class 532-570 series.” However, the patenting probability for cancer related applications is markedly …

Patent-Ineligibility of Medical Diagnostics, Life Sciences Discoveries Arrests U.S. Progress

In a research project funded by the Austrian Science Fund (FWF), evidence emerged that a higher expression of the GIRK1 protein in malignant tissue samples was linked …
By Steve Brachmann
2 years ago 3

Novartis acquires French radiopharmaceutical firm for oncology drug after losing patent protection for Gleevec

Novartis has agreed to acquire French radiopharmaceutical firm Advanced Accelerator Applications (AAA) in a deal which values AAA at $3.9 billion USD. The deal, funded through short- and …
By Steve Brachmann
2 years ago 0

Eli Lilly patent covering Alimta lung cancer treatment upheld in final written decision from PTAB

On Thursday, October 5th, a final written decision issued by the Patent Trial and Appeal Board (PTAB) upheld a series of 22 claims from a patent owned by …
By Steve Brachmann
2 years ago 0

Senate passes 21st Century Cures Act, President Obama expected to quickly sign bill into law

Earlier today, by a vote of 94 to 5, the United States Senate overwhelmingly passed the 21st Century Cures Act. Having passed in the House, the Cures Act now …
By Gene Quinn
3 years ago 6

U.S. ITC recommends exclusion order for radiotherapy and cancer treatment technologies

A complaint regarding Elekta’s radiotherapy and cancer treatment technologies was filed by Palo Alto, CA-based Varian Medical Systems (NYSE:VAR) in September 2015. The complaint alleged that …
By Steve Brachmann
3 years ago 0

$1.5 billion Celator purchase buoys the financial future of Jazz Pharmaceuticals’ oncology division

Of particular interest in this deal is a drug in Celator’s pipeline is Vyxeos (cytarabine:daunorubicin), an injectable liposomal treatment for blood cancers, especially acute myeloid …
By Steve Brachmann
3 years ago 0

Freezing Out Cancer? How scientists are using cryo-electron microscopy to make advances in cancer research

Scientists led by Sriram Subramaniam, PhD, of the National Cancer Institute (NCI) Center for Cancer Research, are using cryo-electron microscopy (cryoEM) to analyze and image molecules, so …
By Angélique McCall
3 years ago 0

Blue Ribbon Panel of Advisors Announced for Biden Cancer Moonshot Initiative

Earlier this week the National Cancer Institute (NCI), which is part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, …
By Gene Quinn
4 years ago 5

Abbott Labs acquires large Alere patent portfolio in $5.8 billion deal, increasing diagnostic lineup

Abbott Laboratories (NYSE:ABT) of Chicago, IL, is poised to surge ahead in the global point-of-care medical diagnostics industry by acquiring Alere Inc. (NYSE:ALR) of Waltham, …
By Steve Brachmann
4 years ago 1

Bolder initiatives needed to take next steps in fight against cancer

February 4 is World Cancer Day... There has been steady progress made in the history of treating cancers of many types since the administration of former U.S …
By Steve Brachmann
4 years ago 4

Canon already with more than 300 patents in 2016, pursues plastics and photoacoustic imaging tech

Our latest survey of patents issued recently to Canon include a couple of imaging technologies related to medical diagnostics, such as is the case with the imaging …
By Steve Brachmann
4 years ago 0

Federal funding for a cancer moonshot is not a terrible idea

To hear Ars Technica say it is ''a terrible idea'' to devote increased funding in order to eradicate cancer is astonishing on many levels. As part of …

Distorting Innovation: Fixed Patent Terms and Underinvestment in Long-term Research

Drugs for the treatment of late-stage cancers are less expensive to develop, in part because late-stage drugs extend patients’ lives for a shorter period of time such …

Bristol-Myers Squibb, Exelixis drugs to aid in fight against kidney cancer

Bristol-Myers Squibb was able to move on in clinical trials of its cancer drug Opvido more quickly than anticipated after kidney cancer patients who were administered the …
By Steve Brachmann
4 years ago 0